ATE176155T1 - Injizierbare amphotericin b enthaltende dispersion - Google Patents

Injizierbare amphotericin b enthaltende dispersion

Info

Publication number
ATE176155T1
ATE176155T1 AT91919697T AT91919697T ATE176155T1 AT E176155 T1 ATE176155 T1 AT E176155T1 AT 91919697 T AT91919697 T AT 91919697T AT 91919697 T AT91919697 T AT 91919697T AT E176155 T1 ATE176155 T1 AT E176155T1
Authority
AT
Austria
Prior art keywords
amphotericin
dispersion containing
containing amphotericin
injectable dispersion
injectable
Prior art date
Application number
AT91919697T
Other languages
English (en)
Inventor
Junzo Seki
Hirofumi Yamamoto
Original Assignee
Nippon Shinyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Shinyaku Co Ltd filed Critical Nippon Shinyaku Co Ltd
Application granted granted Critical
Publication of ATE176155T1 publication Critical patent/ATE176155T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT91919697T 1990-11-16 1991-11-15 Injizierbare amphotericin b enthaltende dispersion ATE176155T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31205790 1990-11-16

Publications (1)

Publication Number Publication Date
ATE176155T1 true ATE176155T1 (de) 1999-02-15

Family

ID=18024709

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91919697T ATE176155T1 (de) 1990-11-16 1991-11-15 Injizierbare amphotericin b enthaltende dispersion

Country Status (6)

Country Link
US (1) US5776904A (de)
EP (1) EP0558750B1 (de)
JP (1) JP3074734B2 (de)
AT (1) ATE176155T1 (de)
DE (1) DE69130832T2 (de)
WO (1) WO1992008467A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291436B1 (en) * 1999-07-16 2001-09-18 International Fiber Corporation Direct action anti-mycotic
US6413537B1 (en) 2000-03-10 2002-07-02 Wisconsin Alumni Research Foundation Nystatin formulation having reduced toxicity
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
JP2004517127A (ja) 2000-12-21 2004-06-10 ネクター セラピューティックス ポリエン抗真菌剤の肺送達
KR20020062494A (ko) * 2001-01-22 2002-07-26 유봉규 단량체 폴리엔마크로리드계열 항생제를 함유한 고체분산체조성물
DE60320283T2 (de) * 2002-10-03 2009-08-27 University of Mississippi, University Zusammensetzungen mit Amphotericin B enthaltend weniger als 4% Verunreinigungen
MXPA06015220A (es) * 2004-06-21 2007-12-13 Nektar Therapeutics Composiciones comprendiendo anfotericina b, metodos y sistemas.
US8513204B2 (en) * 2004-06-21 2013-08-20 Novartis Ag Compositions comprising amphotericin B, mehods and systems
WO2006082588A2 (en) * 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
WO2008063756A2 (en) * 2006-10-03 2008-05-29 Accentia Biopharmaceuticals, Inc. Mucosally non-irritative amphotericin b formulations and methods for treating non-invasive fungus-induced mucositis

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3928570A (en) * 1971-11-29 1975-12-23 Squibb & Sons Inc Amphotericin complexes
US4002741A (en) * 1974-04-24 1977-01-11 Valter Osvaldovich Kulbakh Meglumine complex fungicidal polyene macrolide antibiotic compositions and treatment method
US4035567A (en) * 1975-10-21 1977-07-12 E. R. Squibb & Sons, Inc. Process for producing the methyl ester of amphotericin B
HU196230B (en) * 1983-12-29 1988-10-28 Chinoin Gyogyszer Es Vegyeszet Process for producing water-soluble forms of polyene antibiotics and pharmaceutics comprising such active ingredient and plant protective with antifungal effect
US5043107A (en) * 1986-08-21 1991-08-27 Vestar Research, Inc. Preparation small unilamellar vesicles including polyene antifungal antibiotics
FR2604903B1 (fr) * 1986-10-08 1989-01-13 Sopar Sa Nv Agents therapeutiques sous forme de particules submicroscopiques contre des parasitoses et compositions pharmaceutiques les contenant
US4822777A (en) * 1987-02-27 1989-04-18 Liposome Technology, Inc. Amphotericin B/cholesterol sulfate composition
US4950477A (en) * 1988-08-23 1990-08-21 Memorial Hospital For Cancer And Allied Dieseas Method of preventing and treating pulmonary infection by fungi using aerosolized polyenes

Also Published As

Publication number Publication date
EP0558750B1 (de) 1999-01-27
EP0558750A4 (en) 1993-10-20
WO1992008467A1 (en) 1992-05-29
EP0558750A1 (de) 1993-09-08
DE69130832D1 (de) 1999-03-11
JP3074734B2 (ja) 2000-08-07
US5776904A (en) 1998-07-07
DE69130832T2 (de) 1999-10-07

Similar Documents

Publication Publication Date Title
DE3853191T2 (de) Arzneimittelträger.
FI935395A (fi) Tyloksapolin käyttö stabilisaattorina ja dispergoivana aineena nanopartikkeleissa
NO931710D0 (no) Fremgangsmaate for fremstilling av en stabil ikkeagglomerende, vandig suspensjon av et oljeopploeselig, polymert, friksjonsreduserende middel
PL279333A1 (en) Emulsion or suspension emulsion of the oil in water type with pesticide action
DE58904670D1 (de) Haftklebrige flaechengebilde.
ATE176155T1 (de) Injizierbare amphotericin b enthaltende dispersion
FI884768A0 (fi) Kompositskiva samt foerfarande och sammansaettning foer framstaellning daerav.
FI906328A0 (fi) En anordning foer kontrollerad administrering av aktiva aemnen i ett funktionerande medium.
DE69202892D1 (de) Föttinger Kupplung mit fester Flüssigkeitsmenge und Haupt- und Hilfsverzögerungskammer.
ATE112584T1 (de) Mit isocyanat reagierende zusammensetzungen.
Poch Fabric and physical properties of soils with Gypsic and Hipergypsic horizons of the Ebro Valley
ES2089047T3 (es) Polimeros en emulsion acuosa preparados con emulsionantes no ionicos reticulables.
DE3671429D1 (de) Augenselektive betablockierende und diese enthaltende zusammensetzungen.
FI853708L (fi) Svaorantaendlig, biologiskt soenderfallande funktionell vaetska.
IT8805215A0 (it) Girello per bambini con sistema di arresto in presenza di gradini o dislivelli.
Hentschel Expectations and perceptions of the wilderness travel experience
Chandler First-time fathers' expectations and experiences of labour and delivery
Wang Stoichiometric interactions of atrazine and hydroxyatrazine with chemically-characterized laurentian soil and its key components
NO930275L (no) Vandige polymerisatpreparater, samt fremstilling og anvendelse
Hemingway JEH MacDonald: the relations of his fine and applied art and his poetry
Ateah The nursing degree: post-basic students' perceptions of its costs and benefits
Sykes Studies with CIS-platinum and its effects on the biological behavior of ⁶⁷Ga-citrate
DE3869232D1 (de) Abkoemmlinge von bornan-3-spiro-l'-cyclopentan und diese enthaltende riechstoffzusammensetzungen.
Hildebrandt Attitudes of principals to policies, procedures, and guidelines for the formal evaluation of teachers
Lau The effect of feedback on awareness of illusory correlation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties